Literature DB >> 18688757

How consistent are health utility values?

Pedro L Ferreira1, Lara N Ferreira, Luis N Pereira.   

Abstract

The use of preference-based generic instruments to measure the health-related quality of life of a general population or of individuals suffering from a specific disease has been increasing. However, there are several discrepancies between instruments in terms of utility results. This study compares SF-6D and EQ-5D when administered to patients with cataracts and aims at explaining the differences. Agreement between EQ-5D and SF-6D health state classifications was assessed by correlation coefficients. Simple correspondence analysis was used to assess the agreement among the instrument's descriptive systems and to investigate similarities between dimensions' levels. Cluster analysis was used to classify SF-6D and EQ-5D levels into homogeneous groups. There was evidence of floor effects in SF-6D and ceiling effects in EQ-5D. Comparisons of means showed that SF-6D values exceeded EQ-5D values. Agreement between both instruments was high, especially between similar dimensions. However, different valuation methods and scoring algorithms contributed to the main differences found. We suggest that one or both instruments should be revised, in terms of their descriptive systems or their scoring algorithms, in order to overcome the weakness found.

Entities:  

Mesh:

Year:  2008        PMID: 18688757     DOI: 10.1007/s11136-008-9368-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  30 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  Quality of life assessment in the community-dwelling elderly: validation of the Assessment of Quality of Life (AQoL) Instrument and comparison with the SF-36.

Authors:  Richard H Osborne; Graeme Hawthorne; Elizabeth A Lew; Len C Gray
Journal:  J Clin Epidemiol       Date:  2003-02       Impact factor: 6.437

Review 3.  A comparative review of four preference-weighted measures of health-related quality of life.

Authors:  Jacek A Kopec; Kevin D Willison
Journal:  J Clin Epidemiol       Date:  2003-04       Impact factor: 6.437

Review 4.  Multi-attribute preference functions. Health Utilities Index.

Authors:  G W Torrance; W Furlong; D Feeny; M Boyle
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

Review 5.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

6.  Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure.

Authors:  Graeme Hawthorne; Richard Osborne
Journal:  Aust N Z J Public Health       Date:  2005-04       Impact factor: 2.939

7.  Measuring health-related utility: why the disparity between EQ-5D and SF-6D?

Authors:  Stirling Bryan; Louise Longworth
Journal:  Eur J Health Econ       Date:  2005-09

8.  Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets.

Authors:  Aki Tsuchiya; John Brazier; Jennifer Roberts
Journal:  J Health Econ       Date:  2005-11-04       Impact factor: 3.883

9.  A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index.

Authors:  Bernie J O'Brien; Marian Spath; Gordon Blackhouse; J L Severens; Paul Dorian; John Brazier
Journal:  Health Econ       Date:  2003-11       Impact factor: 3.046

10.  A comparison of the EQ-5D and SF-6D across seven patient groups.

Authors:  John Brazier; Jennifer Roberts; Aki Tsuchiya; Jan Busschbach
Journal:  Health Econ       Date:  2004-09       Impact factor: 3.046

View more
  9 in total

1.  A preference-based measure of health: the VR-6D derived from the veterans RAND 12-Item Health Survey.

Authors:  Alfredo J Selim; William Rogers; Shirley X Qian; John Brazier; Lewis E Kazis
Journal:  Qual Life Res       Date:  2011-02-19       Impact factor: 4.147

2.  Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D.

Authors:  A Szende; N K Leidy; E Ståhl; K Svensson
Journal:  Qual Life Res       Date:  2008-12-23       Impact factor: 4.147

Review 3.  Advances in the Functional Assessment of Patients with Sarcoma.

Authors:  Duncan C Ramsey; Kenneth R Gundle
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Health-State Utilities in Liver Cirrhosis: A Cross-sectional Study.

Authors:  Peyman Adibi; Leila Akbari; Leila Sadat Kahangi; Fatemeh Abdi
Journal:  Int J Prev Med       Date:  2012-03

5.  Reliability and validity of the Portuguese version of the Generalized Anxiety Disorder (GAD-7) scale.

Authors:  Tiago V Sousa; Vânia Viveiros; Maria V Chai; Filipe L Vicente; Gustavo Jesus; Maria J Carnot; Ana C Gordo; Pedro L Ferreira
Journal:  Health Qual Life Outcomes       Date:  2015-04-25       Impact factor: 3.186

6.  Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.

Authors:  Takeru Shiroiwa; Takashi Fukuda; Shunya Ikeda; Ataru Igarashi; Shinichi Noto; Shinya Saito; Kojiro Shimozuma
Journal:  Qual Life Res       Date:  2015-08-25       Impact factor: 4.147

Review 7.  Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study.

Authors:  Gordon Ward Fuller; Monica Hernandez; David Pallot; Fiona Lecky; Mathew Stevenson; Belinda Gabbe
Journal:  Value Health       Date:  2016-12-28       Impact factor: 5.725

8.  Health state utilities for skeletal-related events secondary to bone metastases.

Authors:  Louis S Matza; Karen Chung; Kate Van Brunt; John E Brazier; Ada Braun; Brooke Currie; Andrew Palsgrove; Evan Davies; Jean-Jacques Body
Journal:  Eur J Health Econ       Date:  2013-01-25

9.  Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults.

Authors:  Lara N Ferreira; Pedro L Ferreira; Filipa P Ribeiro; Luis N Pereira
Journal:  Health Qual Life Outcomes       Date:  2016-06-08       Impact factor: 3.186

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.